推官网,引流量

直推官网引流,大量子站导流 效果持久显著

批量建站,提收录

形成站群推广模式 让搜索引擎大量收录!

提权重,树权威

实现权重提升 树立行业权威

部署快,自主可控

免费下载

省成本,提效率

多分站齐推广,性价比高 批量数据分析,帮助及时调整优化

关于OD
关于OD
一又友装修完透风三个月,入住的时间也曾有股滋味。 测了甲醛,达标。但那股说不清的
关于OD
不雅点网讯:5月21日,福州市台江区书记,将在2026年中国福州海外招商月行径技
关于OD
5月16日晚,昆山奥体中心,江苏足球超等联赛迎来精彩对决,苏州队镇守主场迎战连云
188金宝博官网app下载 5月16日晚,苏超苏州主场迎战连云港,上海戏校校长、
北京时刻5月20日凌晨1点,2026年谷歌I/O大会矜重演出,AI依旧是弥散的主
【【【序论:iQOO的数字系列旗舰,迎来了新成员】】】 无人不晓,在iQOO的旗

OD资讯

ODZIXUN

OD资讯

查看更多
  • OD体育

    OD体育

  • 关于OD

    关于OD

  • OD资讯

    OD资讯

  • OD盘口

    OD盘口

OD盘口

  • OD盘口

OD体育(ODSports)官网入口

临床医学名词词典
首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
Hurthle cell tumor of thyroid相关文献:
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force.
Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460.
PMID:25900731
Hurthle cell lesions of the thyroid: Progress made and challenges remaining.
Wong KS, Angell TE, Barletta JA, Krane JF.
Cancer Cytopathol. 2021 May;129(5):347-362. doi: 10.1002/cncy.22375. Epub 2020 Oct 27.
PMID:33108684
Genetics, Diagnosis, and Management of Hurthle Cell Thyroid Neoplasms.
McFadden DG, Sadow PM.
Front Endocrinol (Lausanne). 2021 Jun 10;12:696386. doi: 10.3389/fendo.2021.696386. eCollection 2021.
PMID:34177816
Hurthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis.
Coca-Pelaz A, Rodrigo JP, Shah JP, Sanabria A, Al Ghuzlan A, Silver CE, Shaha AR, Angelos P, Hartl DM, Mäkitie AA, Olsen KD, Owen RP, Randolph GW, Simó R, Tufano RP, Kowalski LP, Zafereo ME, Rinaldo A, Ferlito A.
Adv Ther. 2021 Oct;38(10):5144-5164. doi: 10.1007/s12325-021-01876-7. Epub 2021 Aug 22.
PMID:34423400
Granular cell tumor of thyroid: a case series with molecular characterization highlighting unique pitfalls.
Srivastava P, Da Cruz Paula A, Weigelt B, Pareja F, Reis-Filho JS, Yip L, Pantanowitz L, Seethala RR.
Endocrine. 2022 May;76(2):395-406. doi: 10.1007/s12020-022-03006-x. Epub 2022 Feb 17.
PMID:35175560
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update.
Bischoff LA, Ganly I, Fugazzola L, Buczek E, Faquin WC, Haugen BR, McIver B, McMullen CP, Newbold K, Rocke DJ, Russell MD, Ryder M, Sadow PM, Sherman E, Shindo M, Shonka DC Jr, Singer MC, Stack BC Jr, Wirth LJ, Wong RJ, Randolph GW.
JAMA Otolaryngol Head Neck Surg. 2024 Mar 1;150(3):265-272. doi: 10.1001/jamaoto.2023.4323.
PMID:38206595
Hurthle cell carcinoma.
Yutan E, Clark OH.
Curr Treat Options Oncol. 2001 Aug;2(4):331-5. doi: 10.1007/s11864-001-0026-4.
PMID:12057113
Hurthle cell tumor.
Chen HY, Benjamin LB, Chen MF.
Int Surg. 1996 Apr-Jun;81(2):168-70.
PMID:8912085
Hurthle-cell neoplasms of the thyroid: An algorithmic approach to pathologic diagnosis in light of molecular advances.
Jalaly JB, Baloch ZW.
Semin Diagn Pathol. 2020 Sep;37(5):234-242. doi: 10.1053/j.semdp.2020.03.004. Epub 2020 May 4.
PMID:32444244
The biology and the genetics of Hurthle cell tumors of the thyroid.
Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M.
Endocr Relat Cancer. 2012 Jul 18;19(4):R131-47. doi: 10.1530/ERC-11-0354. Print 2012 Aug.
PMID:22514109
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3